1569.7000 -11.80 (-0.75%)
NSE Dec 02, 2025 15:53 PM
Volume: 17,568
 

1569.70
-0.75%
BOB Capital Markets Ltd.
Q2 revenue/PAT above our estimates due to better traction in both base and acquired businesses
Motilal Oswal increased Neutral price target of Eris Lifesciences Ltd. to 1530.0 on 12 Nov, 2025.
More from Eris Lifesciences Ltd.
Recommended